StonvexLoading…
StonvexStonvexStonvexCore line items from TKO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.60B | $4.74B | $1.12B | $1.31B |
Operating Income | $338.48M | $835.01M | $171.96M | $368.31M |
Net Income | $89.35M | $195.40M | $41.01M | $98.36M |
EPS (Diluted) | $1.12 | $2.26 | $0.47 | $1.17 |
Total Assets | $16.02B | $15.50B | $15.55B | $15.34B |
Total Liabilities | $7.50B | $6.25B | $6.10B | $4.98B |
Cash & Equivalents | $788.89M | $831.10M | $861.41M | $535.06M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 194.63M | 194.01M | 193.37M | 190.45M |